Functional Variation of Rev and RRE Activity During HIV Infection
Functional Variation of Rev and RRE Activity During HIV Infection
批准号:
8708170
负责人:
MARIE-LOUISE HAMMARSKJOLD
金额:
$29.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2017-05-31
关键词:
AddressAffectBindingBinding SitesCell Culture TechniquesCellsClinicalComplexDNA Sequence RearrangementDataElementsEquilibriumFundingGrantHIVHIV InfectionsHIV therapyImmuneImmune systemIndividualInfectionLaboratoriesManuscriptsModelingPathway interactionsPatientsPlayProteinsPublicationsRNARoleStagingStructureTimeVariantViralViral GenomeViral ProteinsViral Structural ProteinsVirusbasedesigngenome sequencinginsightnovelpublic health relevanceresearch studyrev Genesstemvirus pathogenesis
中文摘要
描述(由申请人提供):这项建议探索了在感染期间患者体内不同的REV/RRE活动的基础,并阐述了RRE的结构如何调节REV功能。它还研究了REV/RRE功能的调节是否在两种不同的临床情景中发挥作用。通过单基因组测序获得的最新数据表明,在受感染的个体中,REV和RRE活性随着HIV的进化而变化,这种变化只是由于REV或RRE序列中的少数几个变化引起的。REV/RRE活性的这种变化可以深刻地影响病毒复制的速度。数据还表明,任何特定的REV序列与不同的RRES配对会导致总体REV/RRE活性水平的显著变化。这强调了将REV和RRE作为源自同一病毒基因组的同源对进行分析的重要性。目前,对于REV或RRE序列的微小变化如何调节它们的联合活动,还没有机械性的理解。这项提案的目的之一就是解决这个问题。我们最近也获得了证明RRE是一种动态RNA结构的数据。特别是,茎环区域III和IV既可以作为单个茎环存在,也可以作为两个单独的茎环存在,这两种结构可能是平衡的。我们的数据表明,与单个茎环IV结构的形成对REV和RRE功能至关重要。另一个目的是研究这一点的机制基础。在最后的目标中,我们还将进一步探索这样的假设,即良好的免疫控制选择REV/RRE活性较低的病毒。此外,我们还将研究REV/RRE活性较低的病毒是否有利于建立潜伏感染细胞。具体目标是:具体目标#1:茎环III/IV RRE序列重排的功能意义是什么?具体目标#2:观察到来自感染患者的特定REV-RRE对的活性差异的基础是什么?具体目标#3:分析REV-RRE在两种不同临床情景下的活性。
英文摘要
DESCRIPTION (provided by applicant): This proposal explores the basis for the different Rev/RRE activities that evolve in patients during infection, and also addresses how the structure of the RRE regulates Rev function. It also examines if the modulation of Rev/RRE function plays a role in two different clinical scenarios. Recent data, obtained by single genome sequencing, show that both Rev and RRE activity in an infected individual vary as HIV evolves, and that this variation arises from only a few changes in either Rev or RRE sequence. This change in Rev/RRE activity can profoundly affect rates of viral replication. The data also show that the pairing of any particular Rev sequence with different RREs leads to significant changes in overall Rev/RRE activity levels. This emphasizes the importance of analyzing Rev and RRE as a cognate pair derived from the same viral genome. At the present time, there is no mechanistic understanding of how small changes in sequence of either Rev or RRE modulate their combined activity. One of the aims of this proposal addresses this issue. We have also recently obtained data that demonstrate that the RRE is a dynamic RNA structure. In particular, stem loop regions III and IV can exist either as a single stem loop or as two separate ones, and the two structures probably are in equilibrium. Our data suggest that the formation of the structure with the individual stem loop IV is critical for Rev and RRE function. Another aim will examine the mechanistic basis for this. In the last aim, we will also further explore the hypothesis that good immune control selects for viruses with lower Rev/RRE activity. In addition we will also examine if viruses with lower Rev/RRE activity are favored in establishment of latently infected cells. The specific aims are: Specific Aim #1: What is the functional significance of the stem loop III/IV RRE sequence rearrangement? Specific Aim #2: What is the basis for the differences in activity that are observed with selected Rev- RRE pairs derived from infected patients? Specific Aim #3: Analysis of Rev-RRE activity in two different clinical scenarios.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host Factors That Restrict HIV mRNA With Retained Introns
-
批准号:10480987
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Effects of HIV Rev on Host Cell Gene Expression
-
批准号:10546602
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Host Factors That Restrict HIV mRNA With Retained Introns
-
批准号:10553285
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Effects of HIV Rev on Host Cell Gene Expression
-
批准号:10673153
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2022
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:9475762
-
项目类别:
-
资助金额:$52.47万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Role of HIV Rev in Reactivation from Latency
-
批准号:9534516
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:10132254
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:9334986
-
项目类别:
-
资助金额:$40.13万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV, HERV-K and Human Cancer
-
批准号:9903256
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2017
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:8465556
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:8858647
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:8915864
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV and ADAR Editing
-
批准号:8481715
-
项目类别:
-
资助金额:$27.37万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Functional Variation of Rev and RRE Activity During HIV Infection
-
批准号:9069936
-
项目类别:
-
资助金额:$29.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
HIV and ADAR Editing
-
批准号:8646880
-
项目类别:
-
资助金额:$15.8万
-
财政年份:2013
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
NXF Proteins, Cofactors and Targets
-
批准号:8217116
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
NXF Proteins, Cofactors and Targets
-
批准号:7786965
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
NXF Proteins, Cofactors and Targets
-
批准号:8019508
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Therapeutic Antisense RNA and The HIV Rev-RRE Pathway
-
批准号:7758737
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
Therapeutic Antisense RNA and The HIV Rev-RRE Pathway
-
批准号:7685081
-
项目类别:
-
资助金额:$26.51万
-
财政年份:2009
-
负责人:MARIE-LOUISE HAMMARSKJOLD
-
依托单位:
海外基金